Insights

About Insights

Our robust database offers access to Health Economics & Outcomes Research (HEOR) studies, patient journey reports, provider targeting lists, enterprise data license, and beyond

Amplity Insights networks with various real-world evidence data sources to compile an unparalleled database of information, providing a unique perspective on patient conditions and provider interactions.

Our data serve as a supplemental source of powerful qualitative data not found elsewhere. The records offer an intimate view of the patient-provider interaction and provide valuable insights including:

The Database

Our data covers over 150,000 physicians from over
40,000 clinics and hospitals across all 50 US states

The data contain much less bias than other sets, and Amplity Health receives data from academic hospitals, small hospitals, and clinics of all sizes. We are agnostic to electronic medical record (EMR) systems and insurance providers. Example use cases of the database include:

Commercial Insights

Amplity Insights gives you actionable insights to help you make more informed strategic decisions while gaining a competitive advantage

Amplity Insights provides clients with a unique data set that offers new insight into patient-provider interactions and a deeper understanding of provider-treatment rationale.

How Amplity Insights can help

By leveraging Amplity Insights, in conjunction with our commercial solutions, the field sales teams benefit from increased insight into trends, while being armed with specific messaging to address competitive threats.

This data can be distributed by geographic region to illuminate current market dynamics. This gives you a real-world understanding of the WHY behind clinical decision-making and patient behaviors.

Case example

We provide detailed data regarding why patients may be discontinuing medication or if they are switching to a competing product.

Market situation

During a new drug launch, our client wanted to understand prescribing trends and the effectiveness of awareness campaigns.

Real insights from physician interactions

Insights into discontinuations
“We did discuss the case with him, and we did try to give him Treatment A at that point, which was given only for 2 cycles due to his renal function abnormality. He became so confused. His mental status changed, and he did not want to take Treatment B anymore. That was stopped and there was improvement in his mental status. We would like to add immunomodulatory agent again, but unfortunately, he had significant side effects of CNS toxicity due to Treatment A, which occasionally can occur."
Insights into discontinuations
“Due to significant side effects of Treatment A, it had to be discontinued after barely a few months… I do not believe that he can receive Treatment A in the future due to his severe fatigue that is associated, and also pancytopenia that seems to be associated, with Treatment A. Now he has been off all treatment for the last 3 weeks and he feels much better.”
Insights into discontinuations
"Other possibilities to add Treatment A, but again the patient is not very enthusiastic about it. After much discussion, we have decided to continue Treatment B and go ahead and add the Treatment C again 20 mg weekly for the next 4 weeks and then see what happens in the next 4 weeks. If he complains of more neuropathy and the disease starts to progress, then obviously we are going to have to go to second-line treatment, which may include either again possibility of adding Treatment A or going to Treatment D, etc.”

Measuring the impact of awareness campaign efforts

The following chart demonstrates how many times providers have mentioned 2 drugs over a set period of time. This is particularly powerful during drug launches or marketing campaigns as it captures a unique measurement of brand and efficacy awareness.

Key takeaway

We can see that, over time, following the approval of Treatment B as a first-line treatment for multiple myeloma, the trend shows a reduction of Treatment A mentions and an increase in Treatment B mentions, suggesting some displacement of Treatment A market share.

Health Economics and Outcomes Research (HEOR) Insights

Amplity Insights provides a more complete picture of the true
patient journey

Clinical decisions made by healthcare providers are dependent upon the evaluation of several key indicators.

Lab test results, imaging results, treatment efficacy, progression of disease, patient-reported symptomatology, and access to care may all play a role in driving treatment decisions.

However, these meaningful data endpoints are not readily captured in commercially available real-world structured databases such as claims or EMR. Amplity Insights is not dependent upon billable events that are captured by charge codes submitted to payors for reimbursement.

The Amplity Insights database contains the full unstructured narratives of
patient-provider encounters as dictated by healthcare providers daily.

Using our proprietary Natural Language Processing (NLP) algorithms, meaningful data endpoints may be quickly extracted and evaluated for specific research questions. Leveraging this rich source of patient-level data, researchers are able to glean insights related to the true prevalence of disease, treatment patterns, rationale for treatment, and patient-reported outcomes.

See how our data was used to understand if the prevalence of
hypoglycemia might be underreported in other medical data sources.

Click the button below for excerpts from a peer-reviewed publication.

View use case

“A unique database with valuable insights, AmplityInsights has been my go-to database for complex questions or when the most up-to-date information is needed."

- HEOR Strategist from one of our Medical Affairs and Market Access Consultancy clients